Griddixdog Griddixdog
Zoekresultaten
Alle resultaten weergeven
  • Registreer
    Log in
    Creëer je account
    Zoeken
    Night Mode

Zoeken

Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken

  • Nieuws Feed
  • EXPLORE
  • Pagina
  • Groepen
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Berichten
  • Blogs
  • Gebruikers
  • Pagina
  • Groepen
  • Events
  • Subodh Adke toegevoegd een audio Networking
    2026-05-05 12:09:56 -
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....
    0 Reacties 0 aandelen 2K Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subodh Adke toegevoegd een audio Networking
    2026-05-05 12:10:22 -
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
    (R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....
    0 Reacties 0 aandelen 2K Views 0 voorbeeld
    Please log in to like, share and comment!
  • Siyara Shah toegevoegd een audio Other
    2026-08-19 03:21:17 -
    Small Molecule Innovator API CDMO Market Sees Rising Adoption in Clinical-Stage Drug Development, Commercial API Manufacturing, and Lifecycle Management
    Market Overview The Small Molecule Innovator API CDMO Market is gaining importance as pharmaceutical companies increasingly outsource active pharmaceutical ingredient development and manufacturing to specialized contract development and manufacturing organizations. Innovator drug developers often require advanced capabilities for complex molecules, stringent quality control,...
    0 Reacties 0 aandelen 819 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Rutuja Deshmukh toegevoegd een audio Other
    2026-07-02 07:39:33 -
    Pharmaceutical CRO Market Competitive Analysis and Key Players
    The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...
    0 Reacties 0 aandelen 2K Views 0 voorbeeld
    Please log in to like, share and comment!
  • Rutuja Deshmukh toegevoegd een audio Other
    2026-07-08 15:48:37 -
    Small Molecule Innovator API CDMO Market Trends in Process Development and Scale-Up
    The global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...
    0 Reacties 0 aandelen 2K Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-05-26 12:44:21 -
    AI Clinical Trial Market Growing at 15% CAGR Through 2034
    According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...
    0 Reacties 0 aandelen 2K Views 0 voorbeeld
    Please log in to like, share and comment!
© 2026 Griddixdog Dutch
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Voorwaarden Privacy Contact Us Bedrijvengids